BACM
ABMD

Blue Arrow Capital Management’s Abiomed Inc ABMD Stock Holding History

Blue Arrow Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-30,000
Closed -$1.14M – 214
2014
Q4 		$1.14M Buy
+30,000
New +$946K 0.13% 136

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Blue Arrow Capital Management's ABMD Position: Q1 2015 in Review

Blue Arrow Capital Management sold out of Abiomed Inc (ABMD) in Q1 2015, closing a stake of 30,000 shares — an estimated $1.14M sold.

Blue Arrow Capital Management first reported a position in ABMD in Q4 2014 and held it in 1 quarter. The position peaked at $1.14M in Q4 2014. 210 funds tracked by Wall St. Rank hold ABMD as of Q1 2015.

  • Blue Arrow Capital Management reported no remaining Abiomed Inc position as of Q1 2015 after selling out during the quarter.
  • Blue Arrow Capital Management sold 30,000 Abiomed Inc shares in Q1 2015, an estimated $1.14M.
  • Blue Arrow Capital Management first reported a position in Abiomed Inc in Q4 2014 and held it in 1 quarter.
  • Blue Arrow Capital Management's Abiomed Inc position peaked at $1.14M in Q4 2014.
  • 210 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2015.

Based on Blue Arrow Capital Management's 13F filing for Q1 2015, filed 15 May 2015.